1

Yoda 1 No Further a Mystery

News Discuss 
In our study, we have been ready to drastically escalate the dose of CX-5461 further than that attained in the primary-in-human study in individuals with hematologic cancers. The RP2D of 475 mg/m2 on days 1, 8, and fifteen of the four-7 days cycle, was dependant on phototoxicity, which occurred In https://robertu998nev8.wikiannouncement.com/user

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story